共 411 条
[1]
Al-Salihi MA(2007)Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme Cell Signal 19 1956-1963
[2]
Ulmer SC(2006)Celecoxib for the prevention of colorectal adenomatous polyps N Engl J Med 355 885-895
[3]
Doan T(2003)A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 891-899
[4]
Nelson CD(2006)A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas Gastroenterology 131 1674-1682
[5]
Crotty T(2006)Celecoxib for the prevention of sporadic colorectal adenomas N Engl J Med 355 873-884
[6]
Prescott SM(2002)Epidemiology of colorectal cancer Br Med Bull 64 1-25
[7]
Stafforini DM(2005)Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 1092-1102
[8]
Topham MK(2003)T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation Nat Med 9 1318-1322
[9]
Arber N(2005)Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 1504-1510
[10]
Eagle CJ(2009)Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age? Expert Opin Ther Targets 13 209-218